1. Home
  2. NSRX vs LOAN Comparison

NSRX vs LOAN Comparison

Compare NSRX & LOAN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

NSRX

Nasus Pharma Ltd. Ordinary Shares

N/A

Current Price

$5.50

Market Cap

63.4M

Sector

Health Care

ML Signal

N/A

Logo Manhattan Bridge Capital Inc

LOAN

Manhattan Bridge Capital Inc

HOLD

Current Price

$4.51

Market Cap

51.9M

Sector

Real Estate

ML Signal

HOLD

Company Overview

Basic Information
Metric
NSRX
LOAN
Founded
2019
1989
Country
Israel
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Real Estate Investment Trusts
Sector
Health Care
Real Estate
Exchange
Nasdaq
Nasdaq
Market Cap
63.4M
51.9M
IPO Year
2025
1999

Fundamental Metrics

Financial Performance
Metric
NSRX
LOAN
Price
$5.50
$4.51
Analyst Decision
Strong Buy
Analyst Count
2
0
Target Price
$20.50
N/A
AVG Volume (30 Days)
4.8K
30.0K
Earning Date
03-20-2026
03-11-2026
Dividend Yield
N/A
10.22%
EPS Growth
N/A
N/A
EPS
N/A
0.46
Revenue
N/A
$7,138,128.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$4.47
P/E Ratio
N/A
$9.72
Revenue Growth
N/A
N/A
52 Week Low
$5.42
$4.29
52 Week High
$9.99
$6.05

Technical Indicators

Market Signals
Indicator
NSRX
LOAN
Relative Strength Index (RSI) 36.47 40.12
Support Level $5.42 $4.45
Resistance Level $5.85 $4.59
Average True Range (ATR) 0.28 0.12
MACD -0.13 0.00
Stochastic Oscillator 3.51 16.88

Price Performance

Historical Comparison
NSRX
LOAN

About NSRX Nasus Pharma Ltd. Ordinary Shares

Nasus Pharma Ltd is a clinical-stage specialty pharmaceutical company focused principally on the development of intranasal drugs to treat emergency medical conditions. It is engaged in developing a number of intranasal powder products based on its a microsphere technology, aimed at assisting patients in several acute emergency situations such as opioid overdose and anaphylactic shock. Its portfolio comprises a number of programs: Intranasal Naloxone completed pivotal study and Intranasal Epinephrine (phase 2) as well as a number of preclinical POC programs.

About LOAN Manhattan Bridge Capital Inc

Manhattan Bridge Capital Inc is a real estate finance company taxed as a REIT that specializes in originating, servicing and managing a portfolio of first mortgage loans. The company offers short-term, secured, non-banking loans which may renew or extend, before or after their initial term expires, to real estate investors to fund their acquisition, renovation, rehabilitation or development of residential or commercial properties located in the New York metropolitan area, including New Jersey and Connecticut, and in Florida.

Share on Social Networks: